CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
3.490
+0.140 (4.18%)
At close: Jun 26, 2026, 4:00 PM EDT
3.410
-0.080 (-2.29%)
After-hours: Jun 26, 2026, 7:55 PM EDT
CervoMed Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for CervoMed stock have an average target of 20.4, with a low estimate of 9.00 and a high estimate of 27. The average target predicts an increase of 484.53% from the current stock price of 3.49.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CervoMed stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 7 | 7 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +616.33% | Jun 25, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $9 | Buy | Reiterates | $9 | +157.88% | Jun 11, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $27 | Buy | Reiterates | $27 | +673.64% | May 19, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $20 | Buy | Maintains | $20 | +473.07% | May 19, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $21 | Buy | Reiterates | $21 | +501.72% | May 18, 2026 |
Financial Forecast
Revenue This Year
228.57K
from 4.01M
Decreased by -94.30%
Revenue Next Year
714.29K
from 228.57K
Increased by 212.50%
EPS This Year
-2.68
from -2.98
EPS Next Year
-2.42
from -2.68
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.6M | 5.0M | |
| Avg | 228,570 | 714,290 | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -60.1% | 2,087.5% | |
| Avg | -94.3% | 212.5% | |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.75 | -1.36 | |
| Avg | -2.68 | -2.42 | |
| Low | -4.34 | -4.60 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.